2.13
price down icon3.81%   -0.10
after-market アフターアワーズ: 2.15 0.02 +0.94%
loading
前日終値:
$2.23
開ける:
$2.27
24時間の取引高:
94,468
Relative Volume:
0.73
時価総額:
$56.49M
収益:
-
当期純損益:
$-19.77M
株価収益率:
-1.3567
EPS:
-1.57
ネットキャッシュフロー:
$-13.07M
1週間 パフォーマンス:
+0.70%
1か月 パフォーマンス:
-19.36%
6か月 パフォーマンス:
-40.75%
1年 パフォーマンス:
+86.52%
1日の値動き範囲:
Value
$2.11
$2.27
1週間の範囲:
Value
$1.80
$2.4849
52週間の値動き範囲:
Value
$0.82
$5.99

MAIA Biotechnology Inc Stock (MAIA) Company Profile

Name
名前
MAIA Biotechnology Inc
Name
セクター
Healthcare (1196)
Name
電話
312 416 8592
Name
住所
444 West Lake Street, Suite 1700, Chicago
Name
職員
18
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
MAIA's Discussions on Twitter

MAIA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MAIA 2.13 56.49M 0 -19.77M -13.07M -1.57
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

MAIA Biotechnology Inc (MAIA) 最新ニュース

pulisher
Nov 19, 2024

Diamond Equity Forecasts MAIA Biotechnology Q1 Earnings - Defense World

Nov 19, 2024
pulisher
Nov 18, 2024

Analysts Set Expectations for MAIA Biotechnology Q1 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 12, 2024

MAIA Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 09, 2024

MAIA Biotechnology Inc (MAIA): A New Perspective - Stocks Register

Nov 09, 2024
pulisher
Nov 08, 2024

MAIA Biotechnology Reveals Promising Phase 2 Trial Results - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

MAIAMAIA Biotechnology, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement - BioSpace

Nov 07, 2024
pulisher
Nov 05, 2024

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - Yahoo Finance

Nov 05, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Stan Smith buys shares worth $250,999 - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Stan Smith buys shares worth $250,999 By Investing.com - Investing.com Canada

Nov 04, 2024
pulisher
Nov 04, 2024

Insider Buying: MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires 22,133 Shares of Stock - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Director Cristian Luput Acquires 22,133 Shares of MAIA Biotechno - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Director Ramiro Guerrero Acquires 88,534 Shares of MAIA Biotechn - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Steven Chaouki buys $55,553 in shares By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Steven Chaouki buys $55,553 in shares - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Luput acquires shares worth $55,553 By Investing.com - Investing.com Nigeria

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Luput acquires shares worth $55,553 - Investing.com

Nov 04, 2024
pulisher
Oct 29, 2024

Cosmo Metals Secures $500,000 for Strategic Expansion - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Antipa Minerals Expands Share Offering on ASX - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

WAM Alternative Assets Expands ASX Securities Offering - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Argent BioPharma Issues New Shares Amidst Strategic Growth - MSN

Oct 29, 2024
pulisher
Oct 28, 2024

MAIA Biotechnology Announces $2.44 Million Private Placement - Business Wire

Oct 28, 2024
pulisher
Oct 25, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.4%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.4% – Time to Sell? - Defense World

Oct 25, 2024
pulisher
Oct 23, 2024

Alterity Therapeutics Prepares for 2024 Annual General Meeting - MSN

Oct 23, 2024
pulisher
Oct 22, 2024

Li Bang International announces pricing of initial public offering - MSN

Oct 22, 2024
pulisher
Oct 15, 2024

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics - BioSpace

Oct 15, 2024
pulisher
Oct 03, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 1.1% - MarketBeat

Oct 03, 2024
pulisher
Sep 27, 2024

BioAge, BKV shares end their first trading day flat after earlier gains - MSN

Sep 27, 2024
pulisher
Sep 27, 2024

Weight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPO - MSN

Sep 27, 2024
pulisher
Sep 21, 2024

Healthcare Stock Performance - Yahoo Finance

Sep 21, 2024
pulisher
Sep 18, 2024

Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Daiwa Securities Group Inc. Invests $82,000 in Haemonetics Co. (NYSE:HAE) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Promising signs for MAIA’s telomere-targeting treatment - The Pharma Letter

Sep 18, 2024
pulisher
Sep 18, 2024

Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 8% - Defense World

Sep 18, 2024
pulisher
Sep 13, 2024

THIO Combo Yields Survival Benefit in Advanced NSCLC - AJMC.com Managed Markets Network

Sep 13, 2024
pulisher
Sep 13, 2024

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Bloomberg

Sep 13, 2024
pulisher
Sep 12, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CAE - PR Newswire

Sep 12, 2024
pulisher
Sep 12, 2024

Summit Therapeutics jumps 4%, raises $235M - MSN

Sep 12, 2024
pulisher
Sep 12, 2024

MAIA Biotechnology - The Pharma Letter

Sep 12, 2024
pulisher
Sep 11, 2024

MAIA Biotechnology Reports Promising Interim Results in Lung Cancer Treatment Study - Vancity Buzz

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA Biotechnology Inc’s latest rating changes from various analysts - Knox Daily

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA reports survival benefit in advanced lung cancer trial - Investing.com

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA Biotech releases Phase II results for THIO - The Pharma Letter

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA reports survival benefit in advanced lung cancer trial By Investing.com - Investing.com Australia

Sep 11, 2024
pulisher
Sep 10, 2024

MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks

Sep 10, 2024
pulisher
Sep 10, 2024

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - StockTitan

Sep 10, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology, Inc. to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

Sep 04, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.9% - MarketBeat

Sep 04, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.9% - Defense World

Sep 04, 2024

MAIA Biotechnology Inc (MAIA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
大文字化:     |  ボリューム (24 時間):